127 related articles for article (PubMed ID: 4089767)
41. [Erectile dysfunction and hypogonadism. Is routine endocrine screening necessary?].
Noldus J; Huland H
Urologe A; 1994 Jan; 33(1):73-5. PubMed ID: 8146936
[TBL] [Abstract][Full Text] [Related]
42. Testosterone and erectile physiology.
Guay AT
Aging Male; 2006 Dec; 9(4):201-6. PubMed ID: 17178555
[TBL] [Abstract][Full Text] [Related]
43. [The immunomodulating and hepatotropic effect of correcting hyperprolactinemia and hypophyseal gonadotropic dysfunction in liver cirrhosis patients].
Okorokov AN
Ter Arkh; 1992; 64(2):25-8. PubMed ID: 1509376
[TBL] [Abstract][Full Text] [Related]
44. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.
Gerstenbluth RE; Maniam PN; Corty EW; Seftel AD
J Androl; 2002; 23(6):922-6. PubMed ID: 12399540
[TBL] [Abstract][Full Text] [Related]
45. Effect of bromocriptine mesylate on induced hyperprolactinemia in stabilized psychiatric outpatients undergoing neuroleptic treatment.
Cohn JB; Brust J; DiSerio F; Singer J
Neuropsychobiology; 1985; 13(4):173-9. PubMed ID: 4047382
[TBL] [Abstract][Full Text] [Related]
46. Idiopathic hyperprolactinemia in a 15-year-old boy: a case report and literature review.
Jaruratanasirikul S; Janejindamai S
J Med Assoc Thai; 1995 Jul; 78(7):388-92. PubMed ID: 7658185
[TBL] [Abstract][Full Text] [Related]
47. [Carbohydrate metabolism in normo- and hyperprolactinemic sterile patients and the possible treatment of sterility in juvenile diabetes mellitus with bromocriptine (Parlodel-Sandoz)].
Alexander H; Ulrich FE; Herter U
Acta Univ Palacki Olomuc Fac Med; 1981; 101():118-24. PubMed ID: 6242682
[No Abstract] [Full Text] [Related]
48. The evolving role of testosterone in the treatment of erectile dysfunction.
Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
[TBL] [Abstract][Full Text] [Related]
49. [Hyperprolactinemia, male impotence, oligozoospermia and the treatment with Bromocriptin (author's transl)].
Schellen TM; Declercq A
Dermatol Monatsschr; 1978 Aug; 164(8):568-70. PubMed ID: 700238
[No Abstract] [Full Text] [Related]
50. [A study on hyperprolactinemia in female patients with alcoholics].
Seki M; Yoshida K; Okamura Y
Arukoru Kenkyuto Yakubutsu Ison; 1991 Feb; 26(1):49-59. PubMed ID: 2069537
[TBL] [Abstract][Full Text] [Related]
51. [Hemochromatosis--a rare cause of hypogonadism].
Rishaug U; Bell H; Haug E
Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2818-9. PubMed ID: 10494202
[TBL] [Abstract][Full Text] [Related]
52. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
53. [State of the breasts in patients with hyperprolactinemia-induced amenorrhea and the effect of the treatment with parlodel].
Prilepskaia VN; Burdina LM; Egorova EB; Vaskakova LA; Kononova EF
Akush Ginekol (Mosk); 1991 May; (5):47-50. PubMed ID: 1897672
[TBL] [Abstract][Full Text] [Related]
54. [Long-term use of parlodel in acromegaly].
Pisarskaia IV; Zefirova GS; Ibragimova GV
Ter Arkh; 1984; 56(10):107-10. PubMed ID: 6523351
[TBL] [Abstract][Full Text] [Related]
55. [Therapeutic efficacy of vaginal administration of bromocryptin in patients with hyperprolactinemia].
Obeid Layon J; Carballar G; Espinosa de los Monteros A; Parra Covarrubias A
Ginecol Obstet Mex; 1993 Sep; 61():254-60. PubMed ID: 8406111
[TBL] [Abstract][Full Text] [Related]
56. Hyperprolactinemia: a possible cause of sexual impotence in male patients undergoing chronic hemodialysis.
Gura V; Weizman A; Maoz B; Zevin D; Ben-David M
Nephron; 1980; 26(1):53-4. PubMed ID: 7393379
[TBL] [Abstract][Full Text] [Related]
57. Hyperprolactinemia in infertile Thai women, its incidence and treatment with bromocriptine.
Srivannaboon S; Ongsangkul T; Tungsubutara V; Makemaharn O; Karavagul C
J Med Assoc Thai; 1985 Dec; 68(12):638-41. PubMed ID: 3831204
[No Abstract] [Full Text] [Related]
58. [Zinc in the treatment of hypogonadism in patients with renal pathology].
Kukhtevich AV; Ermolenko VM; Bunatian AF; Gitel' EP; Nosova AA
Ter Arkh; 1988; 60(6):79-82. PubMed ID: 3206378
[TBL] [Abstract][Full Text] [Related]
59. An out-patient approach to sexual problems in uremic patients. An experience in Turin.
Pacitti A; Segoloni GP; Gallone G; Fonzo D; Vercellone A
Contrib Nephrol; 1990; 77():45-55. PubMed ID: 2344745
[No Abstract] [Full Text] [Related]
60. [Psychological and physiological factors in the etiology of hyperprolactinemic disorders of the menstrual cycle in women in a regular hemodialysis program].
Cepický P; Burdová I; Sulková S; Roth Z; Stroufová A
Cesk Gynekol; 1986 May; 51(4):251-7. PubMed ID: 3719733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
